Summary
26 / 100 · Bulios Score
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- Revenue fell by 15% a year over the last 3 years.
- Repaying its net debt would take 8.4 years of operating profit.
- The share price is above the Bulios Fair Price.
- It reports a profit, yet spends more cash than it brings in.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 71.0 KRW for 1 KRW of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (KRW)
Diluted EPS (KRW)
- Analyst estimate
Revenue grew by 32% a year over 5 years. Over the last 3 years it fell by 15% a year.
Growth in detailDoes it make money?
ReasonablyWhere 100 KRW of revenue goes
- Cost of sales 62 KRW
- Research and development 1.5 KRW
- Sales and administration 28 KRW
- Taxes and other 4.4 KRW
- Net profit 4.2 KRW
Net profit, industry median (Chemicals) 4.6 KRW
Out of every 100 KRW of revenue, 4.2 KRW is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail